Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PhaseBio Pharmaceuticals Inc | 132,502 | reported | 20 May 2022 | tx 33+1,616,317−112,169 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 May 2022 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 10,918 | 0.68 USD | |
| 24 Feb 2022 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 82,500 | 0.00 USD | deriv |
| 24 Feb 2022 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 385,000 | 0.00 USD | deriv |
| 19 Nov 2021 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 5,623 | 2.01 USD |
| 03 Nov 2021 | EXERCISE | PhaseBio Pharmaceuticals Inc | 20,000 | 1.24 USD |
| 03 Nov 2021 | EXERCISE | PhaseBio Pharmaceuticals Inc | 20,000 | 1.24 USD | deriv |
| 27 Aug 2021 | EXERCISE | PhaseBio Pharmaceuticals Inc | 20,000 | 1.24 USD |
| 27 Aug 2021 | EXERCISE | PhaseBio Pharmaceuticals Inc | 20,000 | 0.00 USD | deriv |
| 20 May 2021 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 3,964 | 2.80 USD |
| 05 Feb 2021 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 234,000 | 0.00 USD | deriv |
| 20 Nov 2020 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 3,643 | 3.00 USD |
| 21 Aug 2020 | EXERCISE | PhaseBio Pharmaceuticals Inc | 10,000 | 1.24 USD |
| 21 Aug 2020 | EXERCISE | PhaseBio Pharmaceuticals Inc | 10,000 | 0.00 USD | deriv |
| 12 Feb 2020 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 290,000 | 0.00 USD | deriv |
| 06 Sept 2019 | EXERCISE | PhaseBio Pharmaceuticals Inc | 19,000 | 1.24 USD |
| 06 Sept 2019 | EXERCISE | PhaseBio Pharmaceuticals Inc | 19,000 | 0.00 USD | deriv |
| 20 May 2019 | EXERCISE | PhaseBio Pharmaceuticals Inc | 19,131 | 1.24 USD |
| 17 May 2019 | EXERCISE | PhaseBio Pharmaceuticals Inc | 19,913 | 2.27 USD |
| 20 May 2019 | EXERCISE | PhaseBio Pharmaceuticals Inc | 19,131 | 0.00 USD | deriv |
| 17 May 2019 | EXERCISE | PhaseBio Pharmaceuticals Inc | 19,913 | 0.00 USD | deriv |
| 27 Feb 2019 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 263,000 | 0.00 USD | deriv |
| 13 Dec 2018 | PURCHASE | PhaseBio Pharmaceuticals Inc | 1,000 | 3.69 USD |
| 07 Dec 2018 | PURCHASE | PhaseBio Pharmaceuticals Inc | 2,200 | 3.88 USD |
| 10 Dec 2018 | PURCHASE | PhaseBio Pharmaceuticals Inc | 800 | 3.85 USD |
| 22 Oct 2018 | CONVERSION | PhaseBio Pharmaceuticals Inc | 310 | — |